Trial Profile
Zotarolimus- vs everolimus-eluting stents in diabetic Korean patients with de novo coronary lesions
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2013
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 01 Oct 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.